Filing Details

Accession Number:
0001209191-12-021779
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-04-04 13:37:03
Reporting Period:
2012-04-02
Filing Date:
2012-04-04
Accepted Time:
2012-04-04 13:37:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
59478 Lilly Eli & Co LLY Pharmaceutical Preparations (2834) 350470950
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1476151 A Enrique Conterno Lilly Corporate Center
Indianapolis IN 46285
Sr. Vp & Pres., Lilly Diabetes No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-04-02 5,000 $40.30 47,012 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,251 Indirect 401(k)
Footnotes
  1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2012.